Collectively, these data suggest that RNA Pol I-driven pathway is significantly altered in the TNBC and TP53 context; knocking down some of the component seems to be essential for the survival of TNBC cells, thus could be a viable option in targeting this pathway in breast cancer. This evidence concerns the gene TP53 and breast carcinoma.